Amanote Research
Register
Sign In
Mechanisms of Quinolone Resistance in a Clinical Isolate of Escherichia Coli Highly Resistant to Fluoroquinolones but Susceptible to Nalidixic Acid.
Antimicrobial Agents and Chemotherapy
- United States
doi 10.1128/aac.35.3.519
Full Text
Open PDF
Abstract
Available in
full text
Categories
Infectious Diseases
Pharmacology
Date
March 1, 1991
Authors
N Moniot-Ville
J Guibert
N Moreau
J F Acar
E Collatz
L Gutmann
Publisher
American Society for Microbiology
Related search
Emergence of a Streptococcus Pneumoniae Clinical Isolate Highly Resistant to Telithromycin and Fluoroquinolones
Journal of Clinical Microbiology
Microbiology
Norfloxacin Resistance in a Clinical Isolate of Escherichia Coli.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Escherichia Coli Resistant to Cephalosporins and Quinolones Is Still Susceptible to the Cephalosporin-Quinolone Ester Ro 23-9424.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Compensatory Evolution in Quinolone Resistant Escherichia Coli
Development and Validation of a Diagnostic DNA Microarray to Detect Quinolone-Resistant Escherichia Coli Among Clinical Isolates
Journal of Clinical Microbiology
Microbiology
nfxC-type Quinolone Resistance in a Clinical Isolate of Pseudomonas Aeruginosa
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
A Novel, Double Mutation in DNA Gyrase a of Escherichia Coli Conferring Resistance to Quinolone Antibiotics.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Characterization of a New TEM-type Beta-Lactamase Resistant to Clavulanate, Sulbactam, and Tazobactam in a Clinical Isolate of Escherichia Coli.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
CTX-M-190, a Novel Β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia Coli Clinical Isolate
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
